id: NEW:baclofen_pharmacotherapy_aud_to_substance_use_treatment_dropout_rate
name: Baclofen Pharmacotherapy for Alcohol Use Disorder â†’ Substance Use Treatment Dropout Rate
from_node:
  node_id: NEW:baclofen_pharmacotherapy_aud
  node_name: Baclofen Pharmacotherapy for Alcohol Use Disorder
to_node:
  node_id: substance_use_treatment_dropout_rate
  node_name: Substance Use Treatment Dropout Rate
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Baclofen at higher doses produces adverse effects including drowsiness, sedation, somnolence,
  and fatigue'
- 'Step 2: These side effects impair daily functioning and quality of life during treatment'
- 'Step 3: Patients may find side effects intolerable, particularly at higher doses'
- 'Step 4: Increased discontinuation of treatment due to adverse events'
- 'Step 5: Higher dropout rates compromise treatment effectiveness and recovery outcomes'
evidence:
  quality_rating: A
  n_studies: 14
  primary_citation: 'Kazumasa Kotake et al. 2025. "Optimal Dose of Baclofen for the Treatment of Alcohol
    Use Disorder: A Systematic Review and Dose-Response Meta-analysis.." https://doi.org/10.1007/s40263-025-01188-2'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis included 14 randomized controlled trials
  - Studies identified through Cochrane, EMBASE, MEDLINE via PubMed, PsycINFO databases
  - ClinicalTrials.gov and International Clinical Trials Registry Platform searches conducted April 2024
  doi: 10.1007/s40263-025-01188-2
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Higher baclofen doses increase treatment dropout due to adverse events, highlighting the
  need to balance therapeutic efficacy with tolerability. The optimal dose range of 50-60 mg/day represents
  an attempt to maximize benefits while minimizing harm.
quantitative_effects:
  sample_size: 1344
moderators:
- name: baclofen_dose
  direction: strengthens
  strength: strong
  description: Higher baclofen doses increase risk of dropout due to adverse events
- name: adverse_event_type
  direction: strengthens
  strength: moderate
  description: Drowsiness, sedation, somnolence, and fatigue were commonly observed adverse events contributing
    to dropout
structural_competency:
  equity_implications: Treatment retention is influenced by structural factors including patient support
    systems, employment flexibility to manage side effects, access to follow-up care for dose adjustment,
    and healthcare provider expertise in managing adverse events. Patients in precarious employment or
    lacking social support may be less able to tolerate side effects, creating disparities in treatment
    retention. Healthcare system capacity for individualized dose titration and close monitoring can mitigate
    dropout risk.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.901548'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
